Semin intervent Radiol 2018; 35(04): 281-289
DOI: 10.1055/s-0038-1673420
Review Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Musculoskeletal Metastases Management: The Interventional Radiologist's Toolbox

Charles Mastier
1   Interventional Radiology Department, CLCC Léon Bérard 28 prom, Lyon, France
,
Ana Gjorgjievska
1   Interventional Radiology Department, CLCC Léon Bérard 28 prom, Lyon, France
,
Arnaud Thivolet
1   Interventional Radiology Department, CLCC Léon Bérard 28 prom, Lyon, France
,
Amine Bouhamama
1   Interventional Radiology Department, CLCC Léon Bérard 28 prom, Lyon, France
,
Marie Cuinet
1   Interventional Radiology Department, CLCC Léon Bérard 28 prom, Lyon, France
,
Franck Pilleul
1   Interventional Radiology Department, CLCC Léon Bérard 28 prom, Lyon, France
,
Lambros Tselikas
2   Department of Interventional Radiology, Gustave Roussy - Cancer Campus, Villejuif, France
,
Thierry de Baère
2   Department of Interventional Radiology, Gustave Roussy - Cancer Campus, Villejuif, France
,
Frederic Deschamps
2   Department of Interventional Radiology, Gustave Roussy - Cancer Campus, Villejuif, France
› Author Affiliations
Further Information

Publication History

Publication Date:
05 November 2018 (online)

Abstract

The prevalence of patients with painful bone metastases is constantly increasing. This is related to the rising incidence of cancer and increasing life expectancy of patients with metastatic stage. Advances in imaging and development of percutaneous techniques have gradually allowed offering minimally invasive acts on these metastases: cementing, vertebral augmentation, osteosynthesis, percutaneous thermal ablation, neurolysis, embolization. The purpose of this article is to present the main tools available to date for the interventional radiologist so that each participant can understand their functioning, indications, and limits.

 
  • References

  • 1 Stewart BW, Wild CP. World Cancer Report 2014 (Print). Lyon, France: IARC Nonserial Publication; 2014
  • 2 Smith HS. Painful osseous metastases. Pain Physician 2011; 14 (04) E373-E403
  • 3 Zhu XC, Zhang JL, Ge CT. , et al. Advances in cancer pain from bone metastasis. Drug Des Devel Ther 2015; 9: 4239-4245
  • 4 McQuay HJ, Collins SL, Carroll D, Moore RA. Radiotherapy for the palliation of painful bone metastases. Cochrane Database Syst Rev 2000; (02) CD001793
  • 5 Kurup AN, Callstrom MR. Expanding role of percutaneous ablative and consolidative treatments for musculoskeletal tumours. Clin Radiol 2017; 72 (08) 645-656
  • 6 Alvarez L, Pérez-Higueras A, Quiñones D, Calvo E, Rossi RE. Vertebroplasty in the treatment of vertebral tumors: postprocedural outcome and quality of life. Eur Spine J 2003; 12 (04) 356-360
  • 7 Anselmetti GC, Manca A, Ortega C, Grignani G, Debernardi F, Regge D. Treatment of extraspinal painful bone metastases with percutaneous cementoplasty: a prospective study of 50 patients. Cardiovasc Intervent Radiol 2008; 31 (06) 1165-1173
  • 8 Phillips FM, Todd Wetzel F, Lieberman I, Campbell-Hupp M. An in vivo comparison of the potential for extravertebral cement leak after vertebroplasty and kyphoplasty. Spine 2002; 27 (19) 2173-2178 , discussion 2178–2179
  • 9 Deschamps F, Farouil G, Hakime A, Teriitehau C, Barah A, de Baere T. Percutaneous stabilization of impending pathological fracture of the proximal femur. Cardiovasc Intervent Radiol 2012; 35 (06) 1428-1432
  • 10 Callstrom MR, Charboneau JW, Goetz MP. , et al. Painful metastases involving bone: feasibility of percutaneous CT- and US-guided radio-frequency ablation. Radiology 2002; 224 (01) 87-97
  • 11 Callstrom MR, Dupuy DE, Solomon SB. , et al. Percutaneous image-guided cryoablation of painful metastases involving bone: multicenter trial. Cancer 2013; 119 (05) 1033-1041
  • 12 McMenomy BP, Kurup AN, Johnson GB. , et al. Percutaneous cryoablation of musculoskeletal oligometastatic disease for complete remission. J Vasc Interv Radiol 2013; 24 (02) 207-213
  • 13 Mavrogenis AF, Angelini A, Vottis C. , et al. Modern palliative treatments for metastatic bone disease: awareness of advantages, disadvantages, and guidance. Clin J Pain 2016; 32 (04) 337-350
  • 14 Wallace AN, Robinson CG, Meyer J. , et al. The metastatic spine disease multidisciplinary working group algorithms. Oncologist 2015; 20 (10) 1205-1215
  • 15 Hentschel SJ, Burton AW, Fourney DR, Rhines LD, Mendel E. Percutaneous vertebroplasty and kyphoplasty performed at a cancer center: refuting proposed contraindications. J Neurosurg Spine 2005; 2 (04) 436-440
  • 16 Jay B, Ahn SH. Vertebroplasty. Semin Intervent Radiol 2013; 30 (03) 297-306
  • 17 Kasper DM. Kyphoplasty. Semin Intervent Radiol 2010; 27 (02) 172-184
  • 18 Katsanos K, Sabharwal T, Adam A. Percutaneous cementoplasty. Semin Intervent Radiol 2010; 27 (02) 137-147
  • 19 Prince EA, Ahn SH. Interventional management of vertebral body metastases. Semin Intervent Radiol 2013; 30 (03) 278-281
  • 20 Lea W, Tutton S. Decision making; osteoplasty, ablation, or combined therapy for spinal metastases. Semin Intervent Radiol 2017; 34 (02) 121-131